Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Public Minutes Health Technology Assessment (HTA) Programme Oversight Committee/ Efficacy and Mechanism Evaluation (EME) Strategy Advisory Committee Joint Meeting Oct 2023

Contents

Published: 22 March 2024

Version: 1.0 Mar 2024

Print this document

Meeting

Health Technology Assessment (HTA) Programme Oversight Committee/ Efficacy and Mechanism Evaluation (EME) Strategy Advisory Committee Joint Meeting

Date

Friday 20 October 2023

Place

The Wesley Hotel and Conference Venue, Euston House,
81 – 103 Euston Street, Greater London, NW1 2EZ

Present: HTA Programme Oversight Committee

  • Professor Andrew Farmer (Chair for HTA Programme Oversight Committee)
  • Professor Peter Brindle
  • Professor Julia Brown
  • Professor Geraldine Macdonald
  • Professor Rupert Pearse
  • Pritpal Virk (PPI Member)
  • Professor Olivia Wu

Observers

  • Mark Townsend (Senior Research Manager)

Apologies

  • Mr Michael Bowdery
  • Professor Anthony De Soyza
  • Dr Janet Diffin
  • Dr Alan McNair
  • Ms Gail Thornton

Present: EME Strategy Advisory Committee

  • Mrs Hayley Hall (PPI Member)
  • Professor Maya Buch
  • Danny McAuley
  • Professor Olga Ciccarelli
  • Professor Patrick Chinnery
  • Dr Malcolm Skingle
  • Dr Florence Theberg

Observers

There are no observers.

Apologies

  • Professor Diana Baralle
  • Mr Mike Batley
  • Mr Michael Bowdery
  • Professor Ian Bruce
  • Professor Paul Dark
  • Dr Janet Diffin
  • Dr Louise Jones
  • Dr Alan McNair
  • Professor John Norrie
  • Professor Stuart Taylor

Present: HTA and EME representatives

  • Professor Andrew Cook (Chair)
  • Ms Sally Bailey
  • Mrs Becky Barnett-Neve
  • Mr Christian Cox
  • Dr Lisa Douet
  • Dr Rob Gray
  • Ms Sharon Gray
  • Dr Neil Henderson
  • Dr Elizabeth Lemm
  • Dr Cristina Lujan Barroso
  • Dr Eve Pearce
  • Dr Natalie Shearwood-Porter
  • Mrs Karen Williams
  • Dr Debbie Willis


Research Priority decisions

The HTA Programme Oversight Committee considered a total of 20 detailed briefing papers (research briefs).The outcomes are listed below:

Prioritisation Committee Joint or Transferred Research Briefs

Call number: Not for advert
Research type: Primary research
Title: Evaluating supplementary interventions and technologies intended to improve the effectiveness of fertility treatments.

Call number: 23/167
Research type: Primary research
Title: Optimising treatment duration with immunomodulators to reduce overtreatment.


Call number: 23/166
Research type: Primary research
Title: L-dopa for neovascular (wet) age-related macular degeneration? Can it reduce the need for anti-VEGF injections.


Prioritisation Committee Primary and Community Based Care

Call number: 23/30
Research type: Feasibility study
Title: Repetitive Transcranial Magnetic Stimulation for depression in adolescents

Call number: Not for advert
Research type: Primary research
Title: Diagnostic accuracy of faecal calprotectin testing in liquid stools compared to formed stools

Call number: 23/159
Research type: Primary research
Title: Recovery check-ups following treatment for problem alcohol and drug use

Call number: 23/160
Research type: Primary research
Title: Management of metabolic morbidity in women and others with PCOS

Prioritisation Committee Hospital based care

Call number: 22/99
Research type: Primary research
Title: Clinical prediction models for early-onset neonatal infection

Call number: 22/89
Research type: Primary research
Title: Janus kinase inhibitors for the treatment of juvenile idiopathic arthritis

Call number: 22/133
Research type: Primary research
Title: Point of care Doppler ultrasound prior to emergency scrotal exploration – resubmission

Call number: 23/31
Research type: Primary research
Title: Prophylactic nebulised antibiotics for patients with a permanent tracheostomy or who have undergone a laryngectomy

Call number: Not for advert
Research type: Primary research
Title: Preoperative rehabilitation for hip and knee replacement

Call number: 23/161
Research type: Primary research
Title: Vagus nerve stimulation for drug-resistant epilepsy

Call number: 23/157
Research type: Primary research
Title: Preoperative rehabilitation and early mobilisation for shoulder replacement

Call number: 23/158
Research type: Primary research
Title: Treatment of steroid-resistant ulcerative colitis with tofacitinib compared with infliximab

Call number: 23/163
Research type: Primary research
Title: Rituximab in Systemic Lupus Erythematosus

Call number: 23/164
Research type: Primary research
Title: Adjunct corticosteroids for infant (under 3 months old) bacterial meningitis


Prioritisation Committee Social Care

Call number: 23/162
Research type: Primary/ and/or secondary research (broad brief)
Title: Therapies for women, children and others who experience domestic abuse

Call number: 23/165
Research type: Primary research
Title: What are the social and mental wellbeing benefits of intergenerational practises in care homes and schools

Commissioning briefs straight to Programme Oversight Committee
National Screening Committee

Call number: Not for advert - return to future POC
Research type: Primary research
Title: A screening blood test to detect a range of cancers (Galleri)

Future HTA Programme Oversight Committee 2024
meetings: 2024 dates

Friday 9 February 2024
Friday 14 June 2024
Friday 18 October 2024